Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Impact of Tumor Regional Involvement on Active Surveillance Outcomes: Validation of the Cumulative Cancer Location Metric in a US Population.

Leong JY, Capella C, Teplitsky S, Gomella LG, Trabulsi EJ, Lallas CD, Chandrasekar T.

Eur Urol Focus. 2019 May 18. pii: S2405-4569(19)30136-1. doi: 10.1016/j.euf.2019.05.001. [Epub ahead of print]

PMID:
31109856
2.

Spatial distribution of biopsy cores and the detection of intra-lesion pathologic heterogeneity.

Calio BP, Deshmukh S, Mitchell D, Roth CG, Calvaresi AE, Hookim K, McCue P, Trabulsi EJ, Lallas CD.

Ther Adv Urol. 2019 Apr 28;11:1756287219842485. doi: 10.1177/1756287219842485. eCollection 2019 Jan-Dec.

3.

Overlapping surgeries: defining the 'critical portions' of the procedure.

Leong JY, Calio B, Shah M, Sullivan P, Trabulsi EJ, Gomella LG, Lallas CD.

Can J Urol. 2019 Apr;26(2):9694-9698.

4.

Medical Evaluation and Management of Male and Female Voiding Dysfunction: A Review.

Murphy A, Teplitsky S, Das AK, Leong JY, Margules A, Lallas CD.

Rom J Intern Med. 2019 Apr 12. pii: /j/rjim.ahead-of-print/rjim-2019-0009/rjim-2019-0009.xml. doi: 10.2478/rjim-2019-0009. [Epub ahead of print]

PMID:
30990789
5.

AUTHOR REPLY.

Calio BP, Lyshchik A, Li J, Stanczak M, Shaw CM, Adamo R, Liu JB, Forsberg F, Lallas CD, Trabulsi EJ, Eisenbrey JR.

Urology. 2018 Nov;121:196. doi: 10.1016/j.urology.2018.05.055. No abstract available.

PMID:
30526907
6.

Patient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic Response.

Shafi AA, Schiewer MJ, de Leeuw R, Dylgjeri E, McCue PA, Shah N, Gomella LG, Lallas CD, Trabulsi EJ, Centenera MM, Hickey TE, Butler LM, Raj G, Tilley WD, Cukierman E, Knudsen KE.

Eur Urol Oncol. 2018 Sep;1(4):325-337. doi: 10.1016/j.euo.2018.04.019. Epub 2018 Jun 6.

PMID:
30467556
7.

PARP-1 regulates DNA repair factor availability.

Schiewer MJ, Mandigo AC, Gordon N, Huang F, Gaur S, de Leeuw R, Zhao SG, Evans J, Han S, Parsons T, Birbe R, McCue P, McNair C, Chand SN, Cendon-Florez Y, Gallagher P, McCann JJ, Poudel Neupane N, Shafi AA, Dylgjeri E, Brand LJ, Visakorpi T, Raj GV, Lallas CD, Trabulsi EJ, Gomella LG, Dicker AP, Kelly WK, Leiby BE, Knudsen B, Feng FY, Knudsen KE.

EMBO Mol Med. 2018 Dec;10(12). pii: e8816. doi: 10.15252/emmm.201708816.

8.

Neoadjuvant Dose-dense Gemcitabine and Cisplatin in Muscle-invasive Bladder Cancer: Results of a Phase 2 Trial.

Anari F, O'Neill J, Choi W, Chen DYT, Haseebuddin M, Kutikov A, Dulaimi E, Alpaugh RK, Devarajan K, Greenberg RE, Bilusic M, Wong YN, Viterbo R, Hoffman-Censits JH, Lallas CD, Trabulsi EJ, Smaldone M, Geynisman DM, Zibelman M, Lin J, Kelly WK, Uzzo R, McConkey D, Plimack ER.

Eur Urol Oncol. 2018 May;1(1):54-60. doi: 10.1016/j.euo.2018.02.007. Epub 2018 Jun 6.

9.

Long Term Surveillance of Renal Cell Carcinoma Recurrence Following Ablation using 2D and 3D Contrast-Enhanced Ultrasound.

Calio BP, Lyshchik A, Li J, Stanczak M, Shaw CM, Adamo R, Liu JB, Forsberg F, Lallas CD, Trabulsi EJ, Eisenbrey JR.

Urology. 2018 Nov;121:189-196. doi: 10.1016/j.urology.2018.05.053. Epub 2018 Oct 30.

PMID:
30384977
10.

Creation of a Novel Digital Rectal Examination Evaluation Instrument to Teach and Assess Prostate Examination Proficiency.

Clements MB, Schmidt KM, Canfield SE, Gilbert SM, Khandelwal SR, Koontz BF, Lallas CD, Liauw S, Nguyen PL, Showalter TN, Trabulsi EJ, Cathro HP, Schenkman NS, Krupski TL.

J Surg Educ. 2018 Mar - Apr;75(2):434-441. doi: 10.1016/j.jsurg.2017.08.012. Epub 2017 Oct 12.

PMID:
28923535
11.

Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date.

Gomella LG, Mann MJ, Cleary RC, Hubosky SG, Bagley DH, Thumar AB, McCue PA, Lallas CD, Trabulsi EJ.

Can J Urol. 2017 Feb;24(1):8620-8626.

12.

Endoscopic Treatment of Upper Tract Urothelial Carcinoma.

Verges DP, Lallas CD, Hubosky SG, Bagley DH Jr.

Curr Urol Rep. 2017 Apr;18(4):31. doi: 10.1007/s11934-017-0675-x. Review.

PMID:
28251485
13.

Prevalence and Characteristics of Patients with Suspected Inherited Renal Cell Cancer: Application of the ACMG/NSGC Genetic Referral Guidelines to Patient Cohorts.

Truong H, Hegarty SE, Gomella LG, Kelly WK, Trabulsi EJ, Lallas CD, Giri VN.

J Genet Couns. 2017 Jun;26(3):548-555. doi: 10.1007/s10897-016-0020-4. Epub 2017 Jan 19.

PMID:
28101821
14.

Delayed renal artery pseudoaneurysm after robotic partial nephrectomy.

Verges DP, Margules A, Weprin S, Ferenczi B, Lallas CD.

J Robot Surg. 2017 Jun;11(2):275-277. doi: 10.1007/s11701-017-0676-2. Epub 2017 Jan 9. No abstract available.

PMID:
28070739
15.

Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case Report.

Kim H, Alshalalfa M, Hoffman-Censits J, Lallas CD, Davicioni E, Lin J, Birbe R, Erho N, Lehrer J, Ashab HA, Takhar M, Olson A, Lam LL, Kelly WK, Knudsen KE, Thangavel C, Seiler R, Feng FY, Schaeffer EM, Trabulsi EJ, Gomella LG, Hurwitz MD, Dicker AP, Den RB.

Urol Case Rep. 2016 Oct 1;9:51-54. eCollection 2016 Nov.

16.

Association of Inflammation prior to Kidney Transplantation with Post-Transplant Diabetes Mellitus.

Cantarin MP, Keith SW, Lin Z, Doria C, Frank AM, Maley WR, Ramirez C, Lallas CD, Shah A, Waldman SA, Falkner B.

Cardiorenal Med. 2016 Aug;6(4):289-300. doi: 10.1159/000446294. Epub 2016 May 18.

17.

Incidental Lymphoma Discovered During Surveillance for Low-Grade Upper Tract Urothelial Carcinoma Treated Ureteroscopically: A Case Report Series.

Hubosky SG, Healy KA, Raval AJ, Lallas CD, Filicko-O'Hara J, Bagley DH.

J Endourol Case Rep. 2016 Feb 1;2(1):14-7. doi: 10.1089/cren.2016.0008. eCollection 2016.

18.

Decipher correlation patterns post prostatectomy: initial experience from 2 342 prospective patients.

Den RB, Santiago-Jimenez M, Alter J, Schliekelman M, Wagner JR, Renzulli Ii JF, Lee DI, Brito CG, Monahan K, Gburek B, Kella N, Vallabhan G, Abdollah F, Trabulsi EJ, Lallas CD, Gomella LG, Woodlief TL, Haddad Z, Lam LL, Deheshi S, Wang Q, Choeurng V, du Plessis M, Jordan J, Parks B, Shin H, Buerki C, Yousefi K, Davicioni E, Patel VR, Shah NL.

Prostate Cancer Prostatic Dis. 2016 Dec;19(4):374-379. doi: 10.1038/pcan.2016.38. Epub 2016 Aug 30.

19.

Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study.

Myers RE, Leader AE, Censits JH, Trabulsi EJ, Keith SW, Petrich AM, Quinn AM, Den RB, Hurwitz MD, Lallas CD, Hegarty SE, Dicker AP, Zeigler-Johnson CM, Giri VN, Ayaz H, Gomella LG.

J Cancer Educ. 2018 Feb;33(1):180-185. doi: 10.1007/s13187-016-1073-7.

PMID:
27418065
20.

Preoperative nomogram to predict the likelihood of complications after radical nephroureterectomy.

Raman JD, Lin YK, Shariat SF, Krabbe LM, Margulis V, Arnouk A, Lallas CD, Trabulsi EJ, Drouin SJ, Rouprêt M, Bozzini G, Colin P, Peyronnet B, Bensalah K, Bailey K, Canes D, Klatte T.

BJU Int. 2017 Feb;119(2):268-275. doi: 10.1111/bju.13556. Epub 2016 Jul 10.

21.

Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk.

Ross AE, Den RB, Yousefi K, Trock BJ, Tosoian J, Davicioni E, Thompson DJ, Choeurng V, Haddad Z, Tran PT, Trabulsi EJ, Gomella LG, Lallas CD, Abdollah F, Feng FY, Klein EA, Dicker AP, Freedland SJ, Karnes RJ, Schaeffer EM.

Prostate Cancer Prostatic Dis. 2016 Sep;19(3):277-82. doi: 10.1038/pcan.2016.15. Epub 2016 May 3.

22.

Robotic VR simulation to measure competency: a step in the right direction.

Lallas CD.

Can J Urol. 2016 Feb;23(1):8167. No abstract available.

23.

Jak2-Stat5a/b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate Cancer.

Talati PG, Gu L, Ellsworth EM, Girondo MA, Trerotola M, Hoang DT, Leiby B, Dagvadorj A, McCue PA, Lallas CD, Trabulsi EJ, Gomella L, Aplin AE, Languino L, Fatatis A, Rui H, Nevalainen MT.

Am J Pathol. 2015 Sep;185(9):2505-22. doi: 10.1016/j.ajpath.2015.04.026.

24.

Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer.

Plimack ER, Dunbrack RL, Brennan TA, Andrake MD, Zhou Y, Serebriiskii IG, Slifker M, Alpaugh K, Dulaimi E, Palma N, Hoffman-Censits J, Bilusic M, Wong YN, Kutikov A, Viterbo R, Greenberg RE, Chen DY, Lallas CD, Trabulsi EJ, Yelensky R, McConkey DJ, Miller VA, Golemis EA, Ross EA.

Eur Urol. 2015 Dec;68(6):959-67. doi: 10.1016/j.eururo.2015.07.009. Epub 2015 Aug 1.

25.

Orbital Compartment Syndrome as the Presenting Sign of Disseminated Intravascular Coagulation From Metastatic Prostatic Cancer to the Orbit.

Truong H, Counsilman MJ, Gooptu M, Pulte E, Prestipino AJ, Lallas CD.

Urology. 2015 Aug;86(2):e7-8. doi: 10.1016/j.urology.2015.05.017. Epub 2015 Jul 10.

PMID:
26165617
26.

Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia.

Liao Z, Gu L, Vergalli J, Mariani SA, De Dominici M, Lokareddy RK, Dagvadorj A, Purushottamachar P, McCue PA, Trabulsi E, Lallas CD, Gupta S, Ellsworth E, Blackmon S, Ertel A, Fortina P, Leiby B, Xia G, Rui H, Hoang DT, Gomella LG, Cingolani G, Njar V, Pattabiraman N, Calabretta B, Nevalainen MT.

Mol Cancer Ther. 2015 Aug;14(8):1777-93. doi: 10.1158/1535-7163.MCT-14-0883. Epub 2015 May 29.

27.

Contrast-Enhanced Subharmonic and Harmonic Ultrasound of Renal Masses Undergoing Percutaneous Cryoablation.

Eisenbrey JR, Shaw CM, Lyshchik A, Machado P, Lallas CD, Trabulsi EJ, Merton DA, Fox TB, Liu JB, Brown DB, Forsberg F.

Acad Radiol. 2015 Jul;22(7):820-6. doi: 10.1016/j.acra.2015.03.008. Epub 2015 Apr 14.

PMID:
25882093
28.

Risk factors for biochemical recurrence after robotic assisted radical prostatectomy: a single surgeon experience.

Tanimoto R, Fashola Y, Scotland KB, Calvaresi AE, Gomella LG, Trabulsi EJ, Lallas CD.

BMC Urol. 2015 Apr 8;15:27. doi: 10.1186/s12894-015-0024-7.

29.

Hematologic Toxicity of Concurrent Administration of Radium-223 and Next-generation Antiandrogen Therapies.

Dan TD, Eldredge-Hindy HB, Hoffman-Censits J, Lin J, Kelly WK, Gomella LG, Lallas CD, Trabulsi EJ, Hurwitz MD, Dicker AP, Den RB.

Am J Clin Oncol. 2017 Aug;40(4):342-347. doi: 10.1097/COC.0000000000000181.

30.

Urologic and endovascular repair of a uretero-iliac artery fistula.

Hirsch LM, Amirian MJ, Hubosky SG, Das AK, Abai B, Lallas CD.

Can J Urol. 2015 Feb;22(1):7661-5.

31.

Novel actions of next-generation taxanes benefit advanced stages of prostate cancer.

de Leeuw R, Berman-Booty LD, Schiewer MJ, Ciment SJ, Den RB, Dicker AP, Kelly WK, Trabulsi EJ, Lallas CD, Gomella LG, Knudsen KE.

Clin Cancer Res. 2015 Feb 15;21(4):795-807. doi: 10.1158/1078-0432.CCR-14-1358.

32.

Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy.

Den RB, Yousefi K, Trabulsi EJ, Abdollah F, Choeurng V, Feng FY, Dicker AP, Lallas CD, Gomella LG, Davicioni E, Karnes RJ.

J Clin Oncol. 2015 Mar 10;33(8):944-51. doi: 10.1200/JCO.2014.59.0026. Epub 2015 Feb 9. Erratum in: J Clin Oncol. 2015 Apr 20;33(12):1416.

33.

A pilot phase II Study of digoxin in patients with recurrent prostate cancer as evident by a rising PSA.

Lin J, Zhan T, Duffy D, Hoffman-Censits J, Kilpatrick D, Trabulsi EJ, Lallas CD, Chervoneva I, Limentani K, Kennedy B, Kessler S, Gomella L, Antonarakis ES, Carducci MA, Force T, Kelly WK.

Am J Cancer Ther Pharmacol. 2014 Sep 7;2(1):21-32.

34.

Treatment of exophytic renal cancer smaller than 3 cm: surgery versus active surveillance.

Lallas CD, Trabulsi EJ, Kaffenberger SD, Touijer KA.

J Urol. 2015 Jan;193(1):16-8. doi: 10.1016/j.juro.2014.10.052. Epub 2014 Oct 16. No abstract available.

PMID:
25444964
35.

Implementing hexaminolevulinate HCl blue light cystoscopy: a nursing perspective.

Calvaresi AE, Trabulsi EJ, Sonzogni M, Gomella LG, Lallas CD, Wachsmuth KS.

AORN J. 2014 Nov;100(5):489-96; quiz 497-9. doi: 10.1016/j.aorn.2013.12.013. Epub 2014 Oct 25.

PMID:
25443119
36.

Predictors of positive surgical margins after radical prostatectomy at a single institution: preoperative and pathologic factors, and the impact of surgeon variability and technique on incidence and location.

Lallas CD, Fashola Y, Den RB, Gelpi-Hammerschmidt F, Calvaresi AE, McCue P, Birbe R, Gomella LG, Trabulsi EJ.

Can J Urol. 2014 Oct;21(5):7479-86.

PMID:
25347375
37.

The effects of fatigue on robotic surgical skill training in Urology residents.

Mark JR, Kelly DC, Trabulsi EJ, Shenot PJ, Lallas CD.

J Robot Surg. 2014 Sep;8(3):269-75. doi: 10.1007/s11701-014-0466-z. Epub 2014 May 14.

PMID:
27637689
38.

Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy.

Den RB, Feng FY, Showalter TN, Mishra MV, Trabulsi EJ, Lallas CD, Gomella LG, Kelly WK, Birbe RC, McCue PA, Ghadessi M, Yousefi K, Davicioni E, Knudsen KE, Dicker AP.

Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):1038-1046. doi: 10.1016/j.ijrobp.2014.04.052. Epub 2014 Jul 8.

39.

The significance of functional renal obstruction in predicting pathologic stage of upper tract urothelial carcinoma.

Amirian MJ, Radadia K, Narins H, Healy KA, Hubosky SG, Bagley D, Trabulsi EJ, Lallas CD.

J Endourol. 2014 Nov;28(11):1379-83. doi: 10.1089/end.2014.0277. Epub 2014 Jul 16.

40.

Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicity.

Plimack ER, Hoffman-Censits JH, Viterbo R, Trabulsi EJ, Ross EA, Greenberg RE, Chen DY, Lallas CD, Wong YN, Lin J, Kutikov A, Dotan E, Brennan TA, Palma N, Dulaimi E, Mehrazin R, Boorjian SA, Kelly WK, Uzzo RG, Hudes GR.

J Clin Oncol. 2014 Jun 20;32(18):1895-901. doi: 10.1200/JCO.2013.53.2465. Epub 2014 May 12.

41.

Percutaneous cryoablation for recurrent low grade renal cell carcinoma after failed nephron-sparing surgery.

Morgan MA, Roberts NR, Pino LA, Trabulsi EJ, Brown DB, Gomella LG, Lallas CD.

Can J Urol. 2013 Oct;20(5):6933-7.

PMID:
24128832
42.

Adjuvant versus salvage radiation therapy for prostate cancer patients with adverse pathologic features: comparative analysis of long-term outcomes.

Mishra MV, Scher ED, Andrel J, Margules AC, Hegarty SE, Trabulsi EJ, Hyslop T, Den RB, Lallas CD, Gomella LG, Dicker AP, Showalter TN.

Am J Clin Oncol. 2015 Feb;38(1):55-60. doi: 10.1097/COC.0b013e318287bb6b.

43.

Identifying barriers to patient acceptance of active surveillance: content analysis of online patient communications.

Mishra MV, Bennett M, Vincent A, Lee OT, Lallas CD, Trabulsi EJ, Gomella LG, Dicker AP, Showalter TN.

PLoS One. 2013 Sep 11;8(9):e68563. doi: 10.1371/journal.pone.0068563. eCollection 2013. Erratum in: PLoS One. 2013;8(9). doi: 10.1371/annotation/88e8da00-ddc9-4855-8d00-4490e1f3b4fd.

44.

Pharmacologic inhibition of Jak2-Stat5 signaling By Jak2 inhibitor AZD1480 potently suppresses growth of both primary and castrate-resistant prostate cancer.

Gu L, Liao Z, Hoang DT, Dagvadorj A, Gupta S, Blackmon S, Ellsworth E, Talati P, Leiby B, Zinda M, Lallas CD, Trabulsi EJ, McCue P, Gomella L, Huszar D, Nevalainen MT.

Clin Cancer Res. 2013 Oct 15;19(20):5658-74. doi: 10.1158/1078-0432.CCR-13-0422. Epub 2013 Aug 13.

45.

Targeting cell cycle and hormone receptor pathways in cancer.

Comstock CE, Augello MA, Goodwin JF, de Leeuw R, Schiewer MJ, Ostrander WF Jr, Burkhart RA, McClendon AK, McCue PA, Trabulsi EJ, Lallas CD, Gomella LG, Centenera MM, Brody JR, Butler LM, Tilley WD, Knudsen KE.

Oncogene. 2013 Nov 28;32(48):5481-91. doi: 10.1038/onc.2013.83. Epub 2013 May 27.

46.

STAT5A/B gene locus undergoes amplification during human prostate cancer progression.

Haddad BR, Gu L, Mirtti T, Dagvadorj A, Vogiatzi P, Hoang DT, Bajaj R, Leiby B, Ellsworth E, Blackmon S, Ruiz C, Curtis M, Fortina P, Ertel A, Liu C, Rui H, Visakorpi T, Bubendorf L, Lallas CD, Trabulsi EJ, McCue P, Gomella L, Nevalainen MT.

Am J Pathol. 2013 Jun;182(6):2264-75. doi: 10.1016/j.ajpath.2013.02.044. Epub 2013 May 7.

47.

Robotic-assistance does not enhance standard laparoscopic technique for right-sided donor nephrectomy.

Liu XS, Narins HW, Maley WR, Frank AM, Lallas CD.

JSLS. 2012 Apr-Jun;16(2):202-7.

48.

Patterns of care for elderly men diagnosed with favorable-risk prostate cancer from 2004 to 2008: a population-based analysis.

Mishra MV, Shen X, Den RB, Champ CE, Trabulsi EJ, Lallas CD, Gomella LG, Dicker AP, Showalter TN.

Am J Clin Oncol. 2013 Dec;36(6):606-11. doi: 10.1097/COC.0b013e318261056c.

PMID:
22892435
49.

Prognostic factors and outcomes after definitive treatment of female urethral cancer: a population-based analysis.

Champ CE, Hegarty SE, Shen X, Mishra MV, Dicker AP, Trabulsi EJ, Lallas CD, Gomella LG, Hyslop T, Showalter TN.

Urology. 2012 Aug;80(2):374-81. doi: 10.1016/j.urology.2012.02.058.

PMID:
22857759
50.

Laparoscopic pelvic nephrectomy: essential preoperative and intraoperative considerations.

Healy KA, Margules A, Kundavaram C, Hubosky SG, Lallas CD.

Can J Urol. 2012 Jun;19(3):6299-302.

PMID:
22704319

Supplemental Content

Loading ...
Support Center